Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...

Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for ...

Lupus is often marked by flares, which is when symptoms are usually more obvious.

Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the formation of a new philanthropic venture fund Lupus Ventures. The Fund is dedicated to advancing ...

Low proteinuria does not indicate better kidney outcomes or treatment response in patients with lupus nephritis; ...

In a new study, researchers have discovered a connection between inflammation in the areas of interstitial fibrosis and tubular atrophy (IFTA).

For people living with lupus, pain can be one of the most persistent and difficult symptoms to manage. But the good news is that a combination of medical treatments, lifestyle changes and ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...

We’re all mostly human. 8% of your genome comes from viruses. In A Nutshell Scientists captured the first detailed images of ...

Johnson & Johnson (JNJ) shares are in focus after two pipeline updates: a Phase 2b win for nipocalimab in systemic lupus ...